Quantum Biopharma Ltd. 6-K Filing
Ticker: QNTM · Form: 6-K · Filed: Dec 8, 2025 · CIK: 1771885
| Field | Detail |
|---|---|
| Company | Quantum Biopharma Ltd. (QNTM) |
| Form Type | 6-K |
| Filed Date | Dec 8, 2025 |
| Pages | 1 |
| Reading Time | 1 min |
| Key Dollar Amounts | $21,225,000 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 6-K filing submitted by Quantum Biopharma Ltd. (ticker: QNTM) to the SEC on Dec 8, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $21,225,000 (ng an aggregate offering price of up to $21,225,000 through HCW as the sales agent. As of t).
How long is this filing?
Quantum Biopharma Ltd.'s 6-K filing is 1 pages with approximately 353 words. Estimated reading time is 1 minutes.
Where can I view the full 6-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 353 words · 1 min read · ~1 pages · Grade level 11.8 · Accepted 2025-12-08 14:39:07
Key Financial Figures
- $21,225,000 — ng an aggregate offering price of up to $21,225,000 through HCW as the sales agent. As of t
Filing Documents
- g085036_6k.htm (6-K) — 24KB
- 0001753926-25-001860.txt ( ) — 25KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. QUANTUM BIOPHARMA LTD. (Registrant) Date December 8, 2025 By /s/ Donal Carroll Donal Carroll Chief Financial Officer